fluorodeoxyglucose f18 has been researched along with Mast Cell Activation Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Lin, C; Liu, F; Sun, YF; Xun-Ze, S | 1 |
Ehrhart, EJ; Griffin, LR; Randall, E; Selmic, LE; Thamm, DH | 1 |
Becherer, A; Dudczak, R; Kletter, K; Szabo, M; Uffmann, M; Valent, P; Zettinig, G | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Mast Cell Activation Disease
Article | Year |
---|---|
Aggressive systemic mastocytosis of colon and lymph node: A case report.
Topics: Colon; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Mastocytosis; Mastocytosis, Systemic; Middle Aged | 2023 |
Pilot study utilizing Fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography for glycolytic phenotyping of canine mast cell tumors.
Topics: Animals; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Glucose; Mastocytosis; Neoplasm Grading; Palpation; Paracentesis; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiography, Thoracic; Radiopharmaceuticals; Ultrasonography | 2018 |
FDG positron emission tomography in patients with systemic mastocytosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Mastocytosis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |